Good morning! Despite believing that headlines on STAT stories are “terrible,” former FDA head Robert Califf said at ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Biotech investors are preparing for what may be the most important clinical trial readout for them this summer.

Lowering drug prices to European benchmarks would ultimately reduce innovation and cost American consumers just over half a ...

U.S. drug overdose deaths fell 27% in 2024, the lowest since 2019, with fentanyl cases sharply down but methamphetamine up, ...

The health of Native American communities is under threat because of massive cuts to federal health services, tribal leaders ...

Ex-FDA chief Robert Califf about HHS Secretary Robert F. Kennedy Jr. — “My primary worry is not the FDA, my worry is the ...

In hours of combative congressional hearings Wednesday, health secretary Robert F. Kennedy Jr. swung between defending ...

The scientists at the University of California, San Francisco and Johns Hopkins University in Baltimore injected an antisense ...

GOP lawmakers tested the limits of how far they could push Kennedy without appearing to undermine him or his MAHA movement.

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

The WHO, which faces an extraordinary financial crunch in the wake of the U.S. withdrawal from the agency, has dramatically ...